Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease

被引：0
|
作者：
Anna-Maria Schneider
Daniel Weghuber
Benjamin Hetzer
Andreas Entenmann
Thomas Müller
Georg Zimmermann
Sebastian Schütz
Wolf-Dietrich Huber
Judith Pichler
机构：
[1] Paracelsus Medical University,Department of Pediatrics
[2] Innsbruck Medical University,Departments of Pediatrics
[3] Paris Lodron University,Department of Mathematics
[4] Paracelsus Medical University,Spinal Cord Injury and Tissue Regeneration Centre Salzburg
[5] Medical University Vienna,Department of Pediatric Nephrology and Gastroenterology
来源：
BMC Gastroenterology | / 18卷
关键词：
Crohn’s disease; Ulcerative colitis; Paediatrics; Integrin antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
    Schneider, Anna-Maria
    Weghuber, Daniel
    Hetzer, Benjamin
    Entenmann, Andreas
    Mueller, Thomas
    Zimmermann, Georg
    Schuetz, Sebastian
    Huber, Wolf-Dietrich
    Pichler, Judith
    [J]. BMC GASTROENTEROLOGY, 2018, 18
  • [2] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S71 - S72
  • [3] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S116 - S116
  • [4] A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
    Aardoom, Martine A.
    Veereman, Gigi
    de Ridder, Lissy
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [5] Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists
    McConachie, Sean M.
    Wilhelm, Sheila M.
    Bhargava, Ashish
    Kale-Pradhan, Pramodini B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (06) : 571 - 579
  • [6] Efficacy of vedolizumab in patients with inflammatory bowel disease and failure of anti-TNF-antibodies
    Hoog, C.
    Eberhardson, M.
    Almer, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S310 - S310
  • [7] Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study
    Hajjat, Temara M.
    Mosha, Maua
    Whaley, Kaitlin G.
    Rosen, Michael J.
    Suppa, Carmine
    Markowitz, James
    Dufour, Lauren
    Sauer, Cary
    Shukla-Udawatta, Monica
    Boyle, Brendan
    Gibson, Meghan
    Shapiro, Jason
    Sams, Derica
    Sylvester, Francisco
    Hunter, Gabriele
    Perez, Maria E.
    Hyams, Jeffrey S.
    [J]. CROHNS & COLITIS 360, 2021, 3 (03)
  • [8] Infliximab use in children and adolescents with inflammatory bowel disease
    de Ridder, Lissy
    Benninga, Marc A.
    Taminiau, Jan A. J. M.
    Hommes, Daan W.
    van Deventer, Sander J. H.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 45 (01): : 3 - 14
  • [9] VEDOLIZUMAB EXPERIENCE IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER OBSERVATIONAL STUDY (VOLCANO)
    Hajjat, Temara
    Mosha, Maua H.
    Suppa, Carmine
    Markowitz, James
    Whaley, Kaitlin G.
    Rosen, Michael J.
    Shukla-Udawatta, Monica
    Boyle, Brendan M.
    Hunter, Gabriele
    Perez, Maria E.
    Hyams, Jeffrey S.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S840 - S841
  • [10] Targeting TNF-α for the treatment of inflammatory bowel disease
    Billiet, Thomas
    Rutgeerts, Paul
    Ferrante, Marc
    Van Assche, Gert
    Vermeire, Severine
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (01) : 75 - 101
12345